| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.31 | 6e-09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.04 |